| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| filingDate |
1998-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af762f22f20395bbcbba523021e89e91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38e19aadfa8807b8503158f23920ea29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64fab76cf8c4b0d6c275783da545ee7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cd37a41c7fd5411aa9e7918d07c5281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21079850d6471f208f76c65e9fd1a751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4b95f0291fec504f6fb70a9ca109c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c075594789f73c69f39b2114355039 |
| publicationDate |
2001-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-0003710-A2 |
| titleOfInvention |
2- [3- {4- [2-tert-Butyl-6- (trifluoromethyl) -4-pyrimidinyl] -1-piperazinyl} propylthio] -4-pyrimidinol fumarate as well as pharmaceuticals containing this compound preparation |
| abstract |
This invention relates to 2- [3- {4- [2-tert-butyl-6- (trifluoromethyl) -4-pyrimidinyl] -1-piperazinyl} propylthio] -4-pyrimidinol fumarate and to is a pharmaceutical composition containing a compound as an active ingredient which is useful for the treatment of diseases affecting the Dopamine D3 ligands. This active ingredient has a higher stability at low pH values and can therefore be used as an active ingredient in pharmaceutical compositions for oral administration. HE |
| priorityDate |
1997-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |